The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

Aim: Irritable bowel syndrome (IBS) is not a life-threatening condition; however, people with IBS have a low quality of life (QOL) thatmight affect their education, social and professional achievements. Many studies have shown that patients who have IBS havelower QOL compared to the general population together with patients who have chronic diseases. The relation between IBS subtypeand QOL is still not clear. For this reason, our study aims to evaluate the relationship between subtypes of the disease and QOL inpatients who have IBS.Material and Methods: The 100 patients with IBS and 100 healthy individuals who were aged from 18 to 65 years, were included inour study. The relationship between disease subtype and quality of life in IBS patients were analyzed.Results: Regarding quality of life between the groups in the examination; the overall health scores were lower at a significant levelin the patients who had IBS subtype as predominant-constipation than those who had IBS subtypes as predominant-diarrheaand mixed type (p=0.013;p=0.045;p

___

  • 1. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clinical Epidemiol 2014;6:71-80.
  • 2. Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neu-rogastroenterol Motil 2010;16:389-400.
  • 3. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
  • 4. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171- 85.
  • 5. Nellesen D, Yee K, Chawla A, et al. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Managed Care Pharm 2013;19:755-64.
  • 6. Gralnek IM, Hays RD, Kilbourne AM, et al. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol 2004;38:782-9.
  • 7. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-60.
  • 8. Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011;45:98-101
  • 9. Singh P, Agnihotri A, Pathak MK, et al. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil 2012;18:324-31.
  • 10. Sinharoy U, Sinharoy K, Mukhopadhyay P, et al. Pattern of irritable bowel syndrome and its impact on quality of life: A tertiary hospital based study from Kolkata on newly diagnosed pa-tients of irritable bowel syndrome attending general medical outpatient department. CHRISMED J Health and Res 2015;3:238-44.
  • 11. Singh P, Staller K, Barshop K, et al. Patients with irritable bowel syndrome-diarrhea have lower disease specific quality of life than irritable bowel syndrome-constipation. World J Gastroenter-ol 2015;21:8103-9.
  • 12. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016;5085:223-7.
  • 13. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:896-904.
  • 14. Ware JE Jr, Sherbourne CD. The MOS 36-item shortform healthsurvey (SF-36). I. Conceptu-alframe workanditemselection. Med Care 1992;30:473-83.
  • 15. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
  • 16. Whitehead WE, Burnett CK, Cook III EW, Taub E. Impact of irritable bowel syndrome on quali-ty of life. Dig Dis Sci 1996;41:2248-53.
  • 17. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33.
  • 18. Strassels SA, Hahn BA. Short form 36 (SF-36) scores in patients with IBS compared with US norms. Gastroenterology 1997;112:44.
  • 19. Mearin F, Balboa A, Badía X, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15:165-72.
  • 20. Jamali R, Jamali A, Poorrahnama M, et al. Evaluation of healthrelated quality of life in irritable bowel syndrome patients. Health Qual Life Outcomes 2012;10:12.
  • 21. Cho HS, Park JM, Lim CH, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 2011;5:29-36.
  • 22. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:896-904.
  • 23. Schmulson M, Ortiz O, Mejia-Arangure JM, et al. Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina. Dig Dis Sci 2007;52:2950-5.
  • 24. Si JM, Wang LJ, Chen SJ, et al. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol 2004;10:1059-64.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Anterior segment parameters and corneal specular microscopy findings in rheumatoid arthritis

Nurdan Gamze TASLI, Yücel KARAKURT, Nurdagül AKTAŞ, Sumeyye Burcu AGCAYAZI, Hayati YILMAZ, Erel İÇEL, Turgay UÇAK

The attitudes and behaviors of mothers who provide toilet training to their healtly children: A qualitative research

Ulviye GÜNAY, Hatice OLTULUOĞLU

Probable “Escitalopram induced” angioedema in a patient with hereditary angioedema

Gökhan AYTEKİN, Ahmet Zafer CALİSKANER, Sevket ARSLAN, Eray YILDIZ, Fatih COLKESEN

Chemotherapeutic effects of doxorubicin loaded PEG coated TiO? nanocarriers on breast cancer cell lines

Erkan GUMUS, Ayca TAS, Yavuz SİLİG, Neşe KEKLİKCİOĞLU ÇAKMAK, Mustafa ATABEY

Comparison of the effects of mitral regurgitation and pulmonary arterial hypertension on left atrial functions

Uğur AKSU

The evaluation of chickenpox in the post-vaccination period in Turkey

Habip ALMİS, Mehmet TEKİN, Ibrahim Hakan BUCAK, Mehmet GEYİK, Fedli Emre KİLİÇ, Davut KAYAK, Mehmet TURGUT, Capan KONCA

Posterior reversible encephalopathy syndrome secondary to preeclampsia-a case report

Burak ESENER, Pamuk Betul ULUCAN ATAŞ, Penpe Gül FIRAT

The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

Ramazan DERTLİ, Yusuf KAYAR, Nurcan UNVER, Ismet KİRPİNAR, Mehmet AGİN

Platelet to lymphocyte ratio is associated with contrast induced nephropathy after primary percutaneous coronary intervention for ST-elevation myocardial infarction section

Gökhan ÇİCEK, Eser AÇIKGÖZ, Sadık Kadri AÇIKGÖZ

Comparison of radiography and computed tomography in emergency department evaluation of ankle trauma

Mustafa AVCI, Yavuz YILMAZ, Serkan YUKSEL, Ibrahim ETLİ, Nalan KOZACI